Nibha Mediratta MD in Clermont, Florida

Home Florida Clermont

Nibha Mediratta MD has Internal Medicine as her primary medical specialty. Their primary office is: 1950 Hospital View Way in Clermont, Florida.

They're a part of the: Nibha Mediratta Md Pl medical group which has around 3 members. You can call their office at 321-274-1864 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, her university is not listed and graduated in 1994 (around 30 years of experience). They are listed as doing telehealth appointments.

Nibha Mediratta MD Office Phone and Directions

Nibha Mediratta MD
Nibha Mediratta Md Pl
1950 Hospital View Way
Clermont, Florida 34711
321-274-1864

Patient Ratings
Please rate your experience with Nibha Mediratta MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 321-274-1864

Enter a starting address:

Healthcare Info for Nibha Mediratta MD

Medical School: Sorry, her university is not listed
Graduation Year: 1994
The Primary Medical Specialty for Nibha Mediratta MD is listed as: Internal Medicine
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 30
PAC (PECOS ID)#: 1658353917
NPI #: 1275584369
NPI Created On: 05/13/2006
NPI Last Updated Listed as: 03/18/2020
Primary Taxonomy Code: 207R00000X
License Number:
ME95217
Listed Gender: Female

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Celtic Insurance Company
Blue Cross Blue Shield
Oscar Insurance Company of Florida
Medicare

They are listed as accepting new patients in some locations.

Languages spoken by staff include: English, Hindi.

Services and Procedures include:

Removal of impact ear wax, one ear
Automated urinalysis test
Hemoglobin a1c level
Coronavirus ag ia
Vaccine for influenza for administration into muscle, 0.5 ml dosage
Routine ekg using at least 12 leads including interpretation and report
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle
New patient office or other outpatient visit, typically 20 minutes
New patient office or other outpatient visit, typically 30 minutes
New patient office or other outpatient visit, typically 45 minutes
Established patient office or other outpatient visit, typically 5 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Physician telephone patient service, 5-10 minutes of medical discussion
Physician telephone patient service, 11-20 minutes of medical discussion
Physician telephone patient service, 21-30 minutes of medical discussion
Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge
Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge
Advance care planning by the physician or other qualified health care professional

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 810876731

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Diabetes

Name of Drug #1: Ozempic

Open Associated Drug #1: 0169-4132-12

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 811253871

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Diabetes

Name of Drug #1: Ozempic

Open Associated Drug #1: 0169-4132-12

Drug or Biological: Drug

Product Category #2: Diabetes

Name Of Drug #2:: RYBELSUS

Associated Drug #2: 0169-4303-13

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 811398089

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Diabetes

Name of Drug #1: Ozempic

Open Associated Drug #1: 0169-4132-12

Drug or Biological: Drug

Product Category #2: Diabetes

Name Of Drug #2:: RYBELSUS

Associated Drug #2: 0169-4303-13

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 811398083

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Diabetes

Name of Drug #1: Ozempic

Open Associated Drug #1: 0169-4132-12

Drug or Biological: Drug

Product Category #2: Diabetes

Name Of Drug #2:: RYBELSUS

Associated Drug #2: 0169-4303-13

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 833497377

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: CARDIOVASCULAR;METABOLIC DISEASE

Name of Drug #1: ELIQUIS

Open Associated Drug #1: 0003-0893-21

Drug or Biological: Drug

Product Category #2: GASTROINTESTINAL

Name Of Drug #2:: COLOGUARD DNA CAPTURE REAGENTS

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Context of payment:: Informational Meal

Record ID:: 834328615

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular and Metabolism

Name of Drug #1: FARXIGA

Open Associated Drug #1: 0310-6205-30